Loganayagam, A., Arenas Hernandez, M., Corrigan, A., Fairbanks, L., Lewis, C. M., Harper, P., . . . Marinaki, A. M. (2013). Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity. Nature Publishing Group.
Citação norma ChicagoLoganayagam, A., et al. Pharmacogenetic Variants in the DPYD, TYMS, CDA and MTHFR Genes Are Clinically Significant Predictors of Fluoropyrimidine Toxicity. Nature Publishing Group, 2013.
ציטוט MLALoganayagam, A., et al. Pharmacogenetic Variants in the DPYD, TYMS, CDA and MTHFR Genes Are Clinically Significant Predictors of Fluoropyrimidine Toxicity. Nature Publishing Group, 2013.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.